Prevymis (letermovir) - Merck (MSD)
Letermovir Use in Heart Transplant Recipients (clinicaltrials.gov) - Apr 26, 2025 - P4 | N=31 | Completed | Sponsor: Tufts Medical Center | Active, not recruiting ➔ Completed | Trial completion date: Dec 2025 ➔ Jan 2025 | Trial primary completion date: Oct 2025 ➔ Jan 2025 
Trial completion • Trial completion date • Trial primary completion date • Cytomegalovirus Infection • Hematological Disorders • Infectious Disease • Neutropenia • Transplantation
http://clinicaltrials.gov/ct2/show/NCT04904614
 
Apr 26, 2025
 
Prev Next